Impact of Aging Population on Market Growth
The global aging population is a key driver of the ACE Inhibitors Market due to the increased prevalence of hypertension and cardiovascular diseases in older adults. As life expectancy rises, so does the need for effective long-term management solutions.
Healthcare providers increasingly rely on ACE inhibitors for their proven efficacy and safety profile in elderly patients. This demographic shift ensures steady demand and encourages the development of age-appropriate formulations and dosing regimens.